| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/18/2006 | WO2006051818A1 Drug for external use and adhesive patch |
| 05/18/2006 | WO2006051732A1 Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
| 05/18/2006 | WO2006051549A2 Combination therapy associating preferably a ceramide with a cytotoxic drug |
| 05/18/2006 | WO2006051406A2 Over dosage indicating medicated film strip |
| 05/18/2006 | WO2006051067A1 A process for preparing formulations of lipophilic active substances by spray freeze drying |
| 05/18/2006 | WO2006050951A1 Novel composition for easing human child birth |
| 05/18/2006 | WO2006050926A2 Extended surface aggregates in the treatment of skin conditions |
| 05/18/2006 | WO2006050631A1 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 05/18/2006 | WO2006050579A1 Solid particles from controlled destabilisation of microemulsions |
| 05/18/2006 | WO2006030402A3 Dual compartment osmotic delivery device |
| 05/18/2006 | WO2006025029A3 Extended release composition of divalproex |
| 05/18/2006 | WO2006023388A3 Biodegradable diblock copolymers having reverse thermal gelation |
| 05/18/2006 | WO2006017787A3 Tablet coating composition |
| 05/18/2006 | WO2006014256A3 System for generating a bioactive dosage form |
| 05/18/2006 | WO2006011001A3 Controlled release compositions of divalproex sodium |
| 05/18/2006 | WO2006007818A3 Method for systemic bio-correction of an organism |
| 05/18/2006 | WO2006002642A3 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 05/18/2006 | WO2005123053A3 Use of cb2 receptors agonists for the treatment of huntington’s disease |
| 05/18/2006 | WO2005120559A3 Charge gradient inhibition of trypanosoma cruzi and other parasite’s invasive action |
| 05/18/2006 | WO2005115346A9 Pharmaceutical composition containing risperidone |
| 05/18/2006 | WO2005115333A3 A biomolecule-containing formulation of increased stability |
| 05/18/2006 | WO2005112896A3 Dosage form for delivery of multiple drug forms |
| 05/18/2006 | WO2005107717A3 Oral dosage form for the extended release of biguanide and sulfonylurea |
| 05/18/2006 | WO2005107713A3 Swellable dosage form comprising gellan gum |
| 05/18/2006 | WO2005105053A3 Active drug delivery in the gastrointestinal tract |
| 05/18/2006 | WO2005105037A3 Use of a viscoelastic composition for treating increased intraocular pressure |
| 05/18/2006 | WO2005102294A3 Transdermal system secured against misuse |
| 05/18/2006 | WO2005102273A3 Pharmaceutical compositions of a biguanide and a sulfonylurea |
| 05/18/2006 | WO2005097672A3 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 05/18/2006 | WO2005092347A3 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle |
| 05/18/2006 | WO2005063202A3 Method for preparing solid dosage form of desmopressin |
| 05/18/2006 | WO2005058935A3 Aqueous suspensions of ciclesonide for nebulisation |
| 05/18/2006 | WO2005058283A3 Stabilised compositions of factor vii polypeptides |
| 05/18/2006 | WO2005058280A3 Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure |
| 05/18/2006 | WO2005051353A8 Pharmaceutical formulations comprising voriconazole |
| 05/18/2006 | WO2005041866A3 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes |
| 05/18/2006 | WO2005013919A3 Treatment using dantrolene |
| 05/18/2006 | WO2005013810A3 Biodegradable embolic agents |
| 05/18/2006 | WO2005011620A3 Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
| 05/18/2006 | WO2005004837A8 Intravaginal drug delivery devices |
| 05/18/2006 | WO2004091533A3 Delivery systems of homogeneous, thermoreversible gel film containing kappa-2 carrageenan |
| 05/18/2006 | WO2004091532A3 Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom |
| 05/18/2006 | WO2002049619A9 Induced phase transition method for the production of microparticles containing hydrophilic active agents |
| 05/18/2006 | US20060106649 Method for programming a patient care device |
| 05/18/2006 | US20060106367 Large volume bolus device and method |
| 05/18/2006 | US20060106361 Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
| 05/18/2006 | US20060106232 atorvastatin hemi-calcium Form X and solvates of given powder X-ray diffraction pattern; small particle size distribution; dosage forms |
| 05/18/2006 | US20060106231 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/18/2006 | US20060106093 Formulation and delivery method to enhance antioxidant potency of Vitamin E |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106057 Stabilization of quinapril using magnesium oxide |
| 05/18/2006 | US20060106052 Method of using sulfonamide substituted imidazoquinolines |
| 05/18/2006 | US20060106044 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/18/2006 | US20060106026 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105985 Treatment of mucositis |
| 05/18/2006 | US20060105983 Cytotoxic agents |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105955 Insulin entrapped within crystallized lecithin, including ascorbyl palmitate and lipoic acid, transdermal delivery |
| 05/18/2006 | US20060105053 Microsphere filled polymer composites |
| 05/18/2006 | US20060105052 Cationic nanoparticle having an inorganic core |
| 05/18/2006 | US20060105051 Manufacture of particles for pulmonary drug delivery by carbon dioxide assisted nebulization |
| 05/18/2006 | US20060105050 Compositions comprising fenofibrate and simvastatin |
| 05/18/2006 | US20060105049 Folic acid-chitosan-DNA nanoparticles |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060105047 Novel prepolymers useful in biomedical devices |
| 05/18/2006 | US20060105046 Polymer conjugates of opioid antagonists |
| 05/18/2006 | US20060105045 Cyclodextrin solubilizers for liquid and semi-solid formulations |
| 05/18/2006 | US20060105044 Sustained release formulations of sotalol |
| 05/18/2006 | US20060105043 Porous nanostructures and methods involving the same |
| 05/18/2006 | US20060105042 axon regeneration kits comprising containers containing fibrinogen, thrombin, calcium chloride, poly/ADP-ribose/polymerase and N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboamide and drug delivery devices; kinase inhibitors |
| 05/18/2006 | US20060105041 4-Hydroxy tamoxifen gel formulations |
| 05/18/2006 | US20060105040 Pharmaceutical tablet and process for making thereof |
| 05/18/2006 | US20060105039 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| 05/18/2006 | US20060105038 Taste-masked pharmaceutical compositions prepared by coacervation |
| 05/18/2006 | US20060105037 Sustained release pharmaceutical preparations and methods for producing the same |
| 05/18/2006 | US20060105036 Threo-dops controlled release formulation |
| 05/18/2006 | US20060105035 Sustained release heterodisperse hydrogel systems for insoluble drugs |
| 05/18/2006 | US20060105034 Formulation and delivery method to enhance antioxidant potency of Vitamin E |
| 05/18/2006 | US20060105033 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 05/18/2006 | US20060105032 Multiple sclerosis treatment |
| 05/18/2006 | US20060105031 Accelerating recovery from trauma |
| 05/18/2006 | US20060105030 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease |
| 05/18/2006 | US20060105026 consists of a naturally occurring or synthetic polymerisable and/or cross-linkable material in particulate form, the polymerizable and/or cross-linkable material being in admixture with particulate material comprising tissue-reactive functional groups |
| 05/18/2006 | US20060105001 drugs specifically bound to synthetic receptors in such a manner that active drug becomes available only in the presence of a targeted pathophysiologic receptor; increasing efficacy and safety, while reducing side effects |
| 05/18/2006 | US20060105000 Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil |
| 05/18/2006 | US20060104999 Composition for solubilization of paclitaxel and preparation method thereof |
| 05/18/2006 | US20060104997 Monoterpene compositions and uses thereof |
| 05/18/2006 | US20060104970 Biological glue based on thrombin-conjugated nanoparticles |
| 05/18/2006 | US20060104942 Anticholesterol agents; anticholesterol agents; cardiovascular disorders; mixture of colony stimulating factor and hepatocyte growth factor |
| 05/18/2006 | US20060104935 Controlled dissolution crosslinked protein crystals |
| 05/18/2006 | US20060104919 Foamable alcohol |
| 05/18/2006 | US20060104918 Antiperspirant aerosol compositions |
| 05/18/2006 | US20060104917 Stable pharmaceutical products |
| 05/18/2006 | US20060104916 Method and apparatus for enhanced size reduction of particles |
| 05/18/2006 | US20060104915 Aerosol dentifrice formulation |
| 05/18/2006 | US20060104913 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 05/18/2006 | US20060104912 Mousse composition |
| 05/18/2006 | US20060104911 Foamable alcohol |